European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 2 October 2026 - 16:00

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ziextenzo, pegfilgrastim, Date of authorisation: 22/11/2018, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 2 October 2026 - 15:50

Human medicines European public assessment report (EPAR): Ziextenzo, pegfilgrastim, Date of authorisation: 22/11/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 2 October 2026 - 14:30

Human medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 2 October 2026 - 14:25

Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 2 October 2026 - 14:01

Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness